European Immunization Week 2018- Statement of Guido Rasi, Executive Director, European Medicines Agency

Posted on: 26/04/2018 - 13:27

Vaccines matter for each of us: yearly, they prevent 2.7 million people from contracting measles, one million from getting whooping cough and two million babies from getting tetanus. They eradicated smallpox. They stopped polio, a dreadful disease affecting millions of children, in almost all... more

Field of Interest: European Union Medical News
Type: News Feed

Survey: Intermediate Care Units (IMCU) Perspective of Internists

Submitted by Catalina on 16 April 2026 - 10:31

Dear Colleagues, 

On behalf of the Acute Medicine and Hospitalism EFIM Working Group, we are conducting a survey to better understand how Intermediate Care Units (IMCUs) are organised and integrated within acute and internal medicine services.

The aim of this initiative is to collect practical insights from national societies in order to:

Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Application withdrawn

Submitted by Anonymous (not verified) on 15 April 2026 - 16:00

Human medicines European public assessment report (EPAR): Jelrix, autologous cartilage-derived articular chondrocytes, in-vitro expanded, Status: Application withdrawn

Human medicines European public assessment report (EPAR): Kygevvi, doxecitine,doxribtimine, Date of authorisation: 26/03/2026, Status: Authorised

Submitted by Anonymous (not verified) on 15 April 2026 - 15:44

Human medicines European public assessment report (EPAR): Kygevvi, doxecitine,doxribtimine, Date of authorisation: 26/03/2026, Status: Authorised

Human medicines European public assessment report (EPAR): Teduglutide Viatris, teduglutide, Date of authorisation: 08/01/2026, Revision: 2, Status: Authorised

Submitted by Anonymous (not verified) on 15 April 2026 - 14:57

Human medicines European public assessment report (EPAR): Teduglutide Viatris, teduglutide, Date of authorisation: 08/01/2026, Revision: 2, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Latest Newsletters

More